Grants & Projects per year
Personal profile
Fingerprint
Dive into the research topics where Amna F Sher is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
-
ZL-1310-003: A Randomized, Open-Label, Phase 3 Study of ZL-1310, a DLL3 Antibody-Drug Conjugate (ADC), Compared to Investigator's Choice Therapy in Participants with Relapsed Small Cell Lung Cancer
Andrzejczyk, A. (CoI), Keresztes, R. (CoI) & Sher, A. F. (CoI)
Zai Lab (US) Limited Liability Company
08/19/26 → 07/7/27
Project: Research
-
Volrustomig (MEDI5752): A Phase II, Multi-Center, Master Protocol to Evaluate the Efficacy and Safety of Volrustomig as Monotherapy or in Combination with Anti-cancer Agents in Participants with Advanced/Metastatic Solid Tumors
Czerwonka, L. (CoI), Guddati, A. (CoI), Keresztes, R. (CoI), Mani, K. (CoI) & Sher, A. F. (CoI)
AstraZeneca Pharmaceuticals LP
07/16/26 → 10/28/26
Project: Research
-
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Subjects with Extensive Stage Small Cell Lung Cancer (MERU)
Keresztes, R. (PI), Sher, A. F. (CoPI) & Grossman, C. (CoPI)
04/21/17 → 02/5/21
Project: Research
-
NRG Oncology Foundation Contract
Adler, H. (CoI), Baer, L. (CoI), Cohen, J. A. (CoI), Farrelly, P. (CoI), Keresztes, R. (CoI), Khan, F. A. (CoI), Mani, K. (CoI), Ryu, S. (CoI), Sher, A. F. (CoI), Stessin, A. M. (CoI), Stopeck, A. (CoI), Waltzer, W. (CoI), Wu, S. (CoI), Pearl, M. (PI), Varughese-Raju, J. (PI), Lu, J. (CoPI), Weiss, T. (CoPI), Choi, M. (CoI), Fitzgerald, J. (CoI), Grossman, C. (CoI), Henretta, M. (CoI), Kim, B. (CoI), Kudelka, A. (CoI), O'Hea, B. (CoI), Valentine, E. (CoI) & Zhang, Y. (CoI)
03/1/14 → 04/20/21
Project: Research
-
Anti-PD-1-Related Exacerbation of Interstitial Lung Disease in a Patient with Non-Small Cell Lung Cancer: A Case Presentation and Review of the Literature
Julie, J. A. & Sher, A., Jul 2 2020, In: Cancer Investigation. 38, 6, p. 365-371 7 p.Research output: Contribution to journal › Review article › peer-review
6 Scopus citations -
Fatal Adverse Events Associated with Pembrolizumab in Cancer Patients: A Meta-Analysis
Sher, A. F., Golshani, G. M. & Wu, S., Feb 7 2020, In: Cancer Investigation. 38, 2, p. 130-138 9 p.Research output: Contribution to journal › Article › peer-review
18 Scopus citations -
Risk stratification of locally advanced non-small cell lung cancer (Nsclc) patients treated with chemo-radiotherapy: An institutional analysis
Sher, A., Medavaram, S., Nemesure, B., Clouston, S. & Keresztes, R., 2020, In: Cancer Management and Research. 12, p. 7165-7171 7 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Interventional endoscopy in the diagnosis and management of pancreatic adenocarcinoma
Khokhar, A. S., Sher, A. F. & Schattner, M., Dec 1 2017, In: Chinese Clinical Oncology. 6, 6, 63.Research output: Contribution to journal › Review article › peer-review
2 Scopus citations -
Anti-vascular endothelial growth factor antibody bevacizumab reduced the risk of anemia associated with chemotherapy - A meta-analysis
Sher, A. & Wu, S., Oct 2011, In: Acta Oncologica. 50, 7, p. 997-1005 9 p.Research output: Contribution to journal › Review article › peer-review
Open Access12 Scopus citations